Rescue, amplification, and large-scale production of helper-dependent adenoviral vectors

Cold Spring Harbor Protocols

Volumn 6, Issue 7, 2011, Pages 857-866

  Palmer, Donna J ^a   Ng, Philip ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; CIS ACTING ELEMENT; HELPER DEPENDENT ADENOVIRUS VECTOR; UNCLASSIFIED DRUG;

ARTICLE; CLINICAL PROTOCOL; CLONING VECTOR; GENE AMPLIFICATION; GENE DELETION; GENE EXPRESSION; GENE LOCUS; GENE SEQUENCE; GENE TRANSFER; GENETIC CODE; GENETIC TRANSFORMATION; GENOMICS; GENOTOXICITY; HELPER VIRUS; HUMAN; HUMAN CELL; LARGE SCALE PRODUCTION; MUTAGENESIS; PLASMID; TRANSGENE; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY; VIRUS INFECTION; ADENOVIRUS; GENE THERAPY; GENE VECTOR; GENETICS; GROWTH, DEVELOPMENT AND AGING; ISOLATION AND PURIFICATION; METHODOLOGY; VIRUS CULTURE;

ADENOVIRIDAE; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HELPER VIRUSES; VIRUS CULTIVATION;

EID: 79960055670     PISSN: None     EISSN: 15596095     Source Type: Journal    
DOI: 10.1101/pdb.prot5627     Document Type: Article

References (14)

1. Bett AJ, Prevec L, Graham FL. 1993. Packaging capacity and stability of human adenovirus type 5 vectors. J Virol 67: 5911-5921.
2. Kochanek S. 1999. High-capacity adenoviral vectors for gene transfer and somatic gene therapy. Hum Gene Ther 10: 2451-2459.
3. Ng P, Graham FL. 2002. Construction of first generation adenoviral vectors. Meth Mol Med 69: 389-414.
4. Ng P, Graham FL. 2004. Helper-dependent adenoviral vectors for gene therapy. In Gene therapy: Therapeutic mechanisms and strategies, 2nd ed. (ed. NS Templeton), pp. 53-70. Marcel Dekker, New York.
5. Ng P, Parks RJ, Graham FL. 2002a. Preparation of helper-dependent adenoviral vectors. Meth Mol Med 69: 371-388.
6. Ng P, Evelegh C, Cummings D, Graham FL. 2002b. Cre levels limit packaging signal excision efficiency in the Cre/loxP helper-dependent adenoviral vector system. J Virol 76: 4181-4189.
7. Nyberg-Hoffman C, Aguilar-Cordova E. 1999. Instability of adenoviral vectors during transport and its implication for clinical studies. Nat Med 5: 955-957.
8. Palmer DJ, Ng P. 2003. Improved system for helper-dependent adenoviral vector production. Mol Ther 8: 846-852.
9. Palmer DJ, Ng P. 2005. Helper-dependent adenoviral vectors for gene therapy. Hum Gene Ther 16: 1-16.
10. Palmer DJ, Ng P. 2011. Characterization of helper-dependent adenoviral vectors. Cold Spring Harb Protoc doi: 10.1101/pdb.prot5628.
11. Parks RJ. 2000. Improvements in adenoviral vector technology: Overcoming barriers for gene therapy. Clin Genet 58: 1-11.
12. Parks RJ, Graham FL. 1997. A helper-dependent system for adenovirus vector production helps define a lower limit for efficient DNA packaging. J Virol 71: 3293-3298.
13. Parks RJ, Amalfitano A. 2002. Separating fact from fiction: Assessing the potential of modified adenovirus vector for use in human gene therapy. Curr Gene Ther 2: 111-133.
14. Parks RJ, Chen L, Anton M, Sankar U, Rudnicki MA, Graham FL. 1996. A helper-dependent adenovirus vector system: Removal of helper virus by Cre-mediated excision of the viral packaging signal. Proc Natl Acad Sci 93: 13565-13570.